Why the study?
The timeline and comparative quantification of pathological changes in hypertensive cardiac remodelling had not been previously established.
Key points are not available for this paper at this time.
Population
Post-mortem tissue from SCD patients with early and advanced HHD and an angiotensin-II hypertensive mouse model
Comparison
Early vs advanced HHD human tissue contrasted to an angiotensin-II-mediated hypertensive mouse model
Design
Cross-species comparative post-mortem and animal model study
Answers are grounded in this paper and cite their sources.
Remodeling timelines in hypertension may refine SCD risk assessment; leaves open targeted interventions in prospective studies.
Hypertension is a major public health concern and poses a significant risk for sudden cardiac death (SCD). However, the characterisation of human tissues tends to be macroscopic, with little appreciation for the quantification of the pathological remodelling responsible for the advancement of the disease. While the components of hypertensive remodelling are well established, the timeline and comparative quantification of pathological changes in hypertension have not been shown before. Here, we sought to identify the phasing of cardiac remodelling with hypertension using post-mortem tissue from SCD patients with early and advanced hypertensive heart disease (HHD). In order to study and quantify the progression of phenotypic changes, human specimens were contrasted to a well-described angiotensin-II-mediated hypertensive mouse model. While cardiomyocyte hypertrophy is an early adaptive response in the mouse that stabilises in established hypertension and declines as the disease progresses, this finding did not translate to the human setting. In contrast, optimising fibrosis quantification methods and applying them to each setting identified perivascular fibrosis as the prevailing possible cause for overall disease progression. Indeed, assessing myocardial inflammation highlights CD45+ inflammatory cell infiltration that precedes fibrosis and is an early-phase event in response to elevated arterial pressures that may underscore perivascular remodelling. Along with aetiology insight, we highlight cross-species comparison for quantification of cardiac remodelling in human hypertension. As such, this platform could assist with the development of therapies specific to the disease phase rather than targeting global components of hypertension, such as blood pressure lowering.
No takes yet. Share an insight, caveat, or question.
Cooper et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: